AKT1 and diabetic kidney disease: In addition, andrographolide not only ameliorated diabetic nephropathy by inhibiting hyperglycemia-induced renal oxidative stress and inflammation via the Akt/NF-κB pathway [40] but also attenuated diabetic retinopathy by inhibiting retinal angiogenesis and inflammation [41].